ArticleVeterinary research communications2025
Clinical evaluation of sarcoptic mange (Sarcoptes scabiei) in maned wolves (Chrysocyon brachyurus).
Article in Veterinary research communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- 2000-2025: A Quarter of a Century of Studies on Pet Ownership in the Amazon-Epidemiological Implications for Public Health.Pathogens (Basel, Switzerland) · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Sarcoptic mange is a disease potentially threatening to Brazilian carnivores, especially maned wolves (Chrysocyon brachyurus). Recently, an outbreak of sarcoptic mange has affected maned wolves in part of their range; therefore, it is a priority to assess the clinical manifestation of the disease. A total of 20 maned wolves were evaluated in Southeast Brazil, 12 of which from research projects and eight were rescued between 2008 and 2023. Since the clinical signs of the sarcoptic mange vary considerably, the maned wolves were classified according to the degree of clinical manifestation and the lesion severity. According to the extension of the body affected by sarcoptic mange, two maned wolves (10%) were classified as level I (< 25% of the body affected), five (25%) as level II (26-50% of the body affected), three (15%) as level III (51-75% of the body affected), and ten maned wolves (50%) as level IV (76-100% of the body affected). By lesion severity, five maned wolves (25%) had type A lesions (mild lesions), ten (50%) had type B lesions, and five (25%) had type C lesions (severe lesions). The maned wolves classified as III-C and IV-C were transferred to captivity to receive intensive veterinary care. The definitive diagnosis was challenging due to the low sensitivity of the available diagnostic tests, suggesting that future research should use a diagnostic protocol that combines blood serum antibody testing with skin scrapings and histopathology.
Indexed as
Identifiers
40381051What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.